Reltecimod

SKU: orb1701434

Description

Reltecimod is a CD28 antagonist investigated for the treatment of severe infections like necrotizing soft tissue infection. Its mechanism involves modulating T-cell co-stimulation, with research applications in immunology and sepsis studied in both in vitro and in vivo experimental models.

Research Area

Immunology & Inflammation, Infectious Disease & Virology

Key Properties

• Target: Antibacterial,Immunology/Inflammation related
• CAS Number: 1447799-33-8
• MW: 1037.19
• Formula: C₄₆H₇₂N₁₀O₁₅S
• SMILES: C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CC1=CC=C(O)C=C1)C(N[C@H](C(N[C@@H](C(O)=O)C)=O)CC(O)=O)=O)=O)C)=O)C(C)C)=O)CC(C)C)=O)CCSC)(=O)[C@H]2N(C([C@@H](NC([C@@H](C)N)=O)CO)=O)CCC2

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Compound Identifiers

PubChem CID

71652162